Back to the main directory
Company Analysis / Equity
- All Aboard the Money Laundering Train; New Reports Implicate More European Banks by Morningstar
- Morningstar | All Aboard the Money Laundering Train; New Reports Implicate More European Banks by Morningstar
- Morningstar | All Aboard the Money Laundering Train; New Reports Implicate More European Banks by Morningstar
- Morningstar | All Aboard the Money Laundering Train; New Reports Implicate More European Banks by Morningstar
- Morningstar | All Aboard the Money Laundering Train; New Reports Implicate More European Banks by Morningstar
- Morningstar | All Aboard the Money Laundering Train; New Reports Implicate More European Banks by Morningstar
- Morningstar | All Aboard the Money Laundering Train; New Reports Implicate More European Banks by Morningstar
- Morningstar | All Aboard the Money Laundering Train; New Reports Implicate More European Banks by Morningstar
- Morningstar | All Aboard the Money Laundering Train; New Reports Implicate More European Banks by Morningstar
- Morningstar | Aon Will Not Pursue Deal With Willis Towers Watson by Morningstar
- BioMerieux Posts Solid 4Q and 2019 Outlook; Slightly Raising Our FVE by Morningstar
- Morningstar | BioMerieux Posts Solid 4Q and 2019 Outlook; Slightly Raising Our FVE. See Updated Analyst Note from 06 Mar 2019 by Morningstar
- Morningstar | JPMorgan's Scale and Product Breadth Should Give the Bank an Advantaged Competitive Position by Morningstar
- Upgrading the Moat Ratings of JPMorgan and Bank of America; Scale, Scope, and the Future of Banking by Morningstar
- Upgrading the Moat Ratings of JPMorgan and Bank of America; Scale, Scope, and the Future of Banking by Morningstar
- Morningstar | Upgrading the Moat Ratings of JPMorgan and Bank of America; Scale, Scope, and the Future of Banking by Morningstar
- Morningstar | ICU Medical Faces a Tough Path to Revenue Growth in 2019, but Profit Outlook Remains Unchanged by Morningstar
- Morningstar | Upgrading the Moat Ratings of JPMorgan and Bank of America; Scale, Scope, and the Future of Banking by Morningstar
- Morningstar | Lack of a Competitive Edge for CyrusOne Limits the Opportunity for Its High Growth to be Profitable by Morningstar
- Morningstar | Insulet Poised for Further Growth and Profitability; Raising Our FVE by Morningstar
- Kingfisher Moat Rating Falls to None as Competition Remains Fierce by Morningstar
- Lowering Kingfisher Moat Rating to None as Efforts to Unify Business Fail to Spark ROIC Increase by Morningstar
- Lowering Kingfisher Moat Rating to None as Efforts to Unify Business Fail to Spark ROIC Increase by Morningstar
- Morningstar | Lowering Kingfisher Moat Rating to None as Efforts to Unify Business Fail to Spark ROIC Increase by Morningstar
- Stericycle Faces Med-Waste Pricing Headwinds and Restructuring, but Growth Opportunities Remain by Morningstar